Craft

IQVIA

Stock Price

$216.3

2024-10-29

Market Capitalization

$39.4 B

2024-10-29

Revenue

$16.3 B

FY, 2025

IQVIA Summary

Company Summary

Overview
IQVIA Holdings (formerly known as QuintilesIMS) is a company that offers clinical research services, data analysis, and information solutions for the life sciences and healthcare industries. It operates in three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment delivers information, technology, and data services to life sciences organizations. The Research & Development Solutions segment focuses on clinical research and clinical trial management. The Contract Sales & Medical Solutions segment covers services for healthcare providers, contract sales, and patient-related activities for biopharmaceutical companies.
Type
Public
Status
Active
Founded
2016
HQ
Durham, NC, US | view all locations
Website
https://www.iqvia.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Ari Bousbib

    Ari Bousbib, Chairman and Chief Executive Officer

    • Trudy Stein

      Trudy Stein, Executive Vice President and Chief Human Resources Officer

    • Jeffrey Spaeder

      Jeffrey Spaeder, Chief Medical and Scientific Officer

    • Eric Sherbet

      Eric Sherbet, Executive Vice President and General Counsel

    Operating MetricsView all

    Backlog

    $27.2B
    9.7%

    FY, 2022

    Remaining Performance Obligations

    $29.2B
    7.4%

    FY, 2022

    Patient Records

    1.2B

    FY, 2022

    LocationsView all

    124 locations detected

    • Durham, NC HQ

      United States

      2400 Ellis Rd

    • Danbury, CT

      United States

      83 Wooster Heights Road

    • Durham, NC

      United States

      4820 Emperor Blvd

    • Buenos Aires, CABA

      Argentina

      Av. Leandro N. Alem 1050, 7° piso

    • Melbourne, VIC

      Australia

      Mezzanine 1 + 2 525 Collins Street

    • North Sydney, NSW

      Australia

      Level 8, 141 Walker Street

    and 118 others

    IQVIA Financials

    Summary Financials

    Revenue (Q1, 2026)
    $4.2B
    Gross profit (Q1, 2026)
    $1.4B
    Net income (Q1, 2026)
    $275.0M
    Cash (Q1, 2026)
    $1.9B
    EBIT (Q1, 2026)
    $514.0M
    Enterprise value
    $53.6B

    Footer menu